Viatrexx-Infla is a Intramuscular; Intravenous; Parenteral; Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Viatrexx Bio Incorporated. The primary component is Anti-interleukin-1.alpha. Immunoglobulin G Rabbit; Aconitum Napellus; Apis Mellifera; Beta-endorphin Human; Bos Taurus Adrenal Gland; Sus Scrofa Adrenal Gland; Atropa Belladonna; Citric Acid Monohydrate; Bos Taurus Solar Plexus; Sus Scrofa Solar Plexus; Bryonia Alba Root; Interleukin-10; Bos Taurus Mesenchyme; Sus Scrofa Mesenchyme; Sodium Pyruvate; Bos Taurus Pineal Gland; Sus Scrofa Pineal Gland; Bos Taurus Pituitary Gland; Sus Scrofa Pituitary Gland; Rancid Beef; Transforming Growth Factor Beta-1; Avotermin.
| Product ID | 73069-249_fc18dd33-0269-4ae7-a325-ed8cf7e47251 |
| NDC | 73069-249 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Viatrexx-Infla |
| Generic Name | Aconitum, Anti-interleukin-1, Apis, Adrenal, Belladonna, Beta Endorphin, Citric Acid, Coelliac Plexus, Bryonia, Interleukin-10, Mesenchyme, Natrum Pyruvicum, Pineal, Pituitary Gland, Pyrogenium, Transforming Growth Factor-1, Transforming Growth Factor-3 |
| Dosage Form | Injection |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS; PARENTERAL; SUBCUTANEOUS |
| Marketing Start Date | 2019-03-29 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | VIATREXX BIO INCORPORATED |
| Substance Name | ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT; ACONITUM NAPELLUS; APIS MELLIFERA; BETA-ENDORPHIN HUMAN; BOS TAURUS ADRENAL GLAND; SUS SCROFA ADRENAL GLAND; ATROPA BELLADONNA; CITRIC ACID MONOHYDRATE; BOS TAURUS SOLAR PLEXUS; SUS SCROFA SOLAR PLEXUS; BRYONIA ALBA ROOT; INTERLEUKIN-10; BOS TAURUS MESENCHYME; SUS SCROFA MESENCHYME; SODIUM PYRUVATE; BOS TAURUS PINEAL GLAND; SUS SCROFA PINEAL GLAND; BOS TAURUS PITUITARY GLAND; SUS SCROFA PITUITARY GLAND; RANCID BEEF; TRANSFORMING GROWTH FACTOR BETA-1; AVOTERMIN |
| Active Ingredient Strength | 31 [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL |
| Pharm Classes | Standardized Insect Venom Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [CS],Bee Venoms [CS],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-05-06 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-05 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-06-19 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-05 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-05 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-05 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-05-06 |
| Ingredient | Strength |
|---|---|
| ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT | 31 [kp_C]/mL |
| SPL SET ID: | 5d195797-ba4a-4791-b805-e28479a722e0 |
| Manufacturer | |
| UNII | |
| UPC Code |